{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:51:43Z","timestamp":1790373103864,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.revmed.2013.04.016","type":"journal-article","created":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T16:24:02Z","timestamp":1370449442000},"page":"166-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Les maladies bulleuses auto-immunes"],"prefix":"10.1016","volume":"35","author":[{"given":"S.","family":"Duvert-Lehembre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2013.04.016_bib0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0151-9638(05)79252-8","article-title":"Molecular advances in pathogenesis of autoimmune blistering skin diseases","volume":"132","author":"Mouquet","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0010","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: a population-based case-control study","volume":"131","author":"Langan","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000315393","article-title":"Sera of elderly bullous pemphigoid patients with associated neurological diseases recognize bullous pemphigoid antigens in the human brain","volume":"57","author":"Chen","year":"2011","journal-title":"Gerontology"},{"key":"10.1016\/j.revmed.2013.04.016_bib0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archderm.141.6.691","article-title":"Prediction of survival for patients with bullous pemphigoid \u2013 A prospective study","volume":"141","author":"Joly","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0030","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archderm.134.9.1075","article-title":"Evaluation of clinical criteria for diagnosis of bullous pemphigoid","volume":"134","author":"Vaillant","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archdermatol.2011.21","article-title":"Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid","volume":"147","author":"Roussel","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yadr.2007.07.013","article-title":"Bullous pemphigoid: physiopathology, clinical features and management","volume":"23","author":"Di Zenzo","year":"2007","journal-title":"Adv Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0045","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0050","first-page":"434","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.revmed.2013.04.016_bib0055","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2133.2002.04835.x","article-title":"Guidelines for the management of bullous pemphigoid","volume":"147","author":"Wojnarowska","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2013.04.016_bib0065","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/jid.2008.412","article-title":"A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study","volume":"129","author":"Joly","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.revmed.2012.12.011","article-title":"Troubles psychiatriques induits par la corticoth\u00e9rapie orale\u00a0: mise au point sur la nature, l\u2019incidence, les facteurs de risque et le traitement","volume":"34","author":"Ricoux","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.04.016_bib0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.revmed.2012.12.005","article-title":"Effets ind\u00e9sirables m\u00e9taboliques et cardiovasculaires des corticoth\u00e9rapies syt\u00e9miques","volume":"34","author":"Fardet","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.04.016_bib0080","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.revmed.2012.12.004","article-title":"Effets ind\u00e9sirables cutan\u00e9s des glucocortico\u00efdes","volume":"34","author":"Guillot","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.04.016_bib0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.revmed.2012.11.005","article-title":"Ost\u00e9oporose cortico-induite","volume":"34","author":"Briot","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.04.016_bib0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archderm.1993.01680220061016","article-title":"Controlled trial of azathioprine and plasma-exchange in addition to prednisolone in the treatment of bullous pemphigoid","volume":"129","author":"Guillaume","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0095","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.143.12.1536","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid","volume":"143","author":"Beissert","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0100","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.1994.01690060083010","article-title":"Nicotinamide and tetracycline therapy of bullous pemphigoid","volume":"130","author":"Fivenson","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0105","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2133.2009.09246.x","article-title":"Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid","volume":"161","author":"Guercan","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0110","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1365-2133.2011.10748.x","article-title":"Successful management of severe infant bullous pemphigoid with omalizumab","volume":"166","author":"Dufour","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0115","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.AOG.0000115506.76104.ad","article-title":"Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigold gestationis","volume":"103","author":"Sitaru","year":"2004","journal-title":"Obst Gynecol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0120","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0151-9638(04)93804-5","article-title":"Pemphigoid gestationis: a study of 20 cases","volume":"131","author":"Mokni","year":"2004","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0125","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2005.12.012","article-title":"The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients","volume":"54","author":"Ambros-Rudolph","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195302000-00001","article-title":"Pemphigus","volume":"32","author":"Lever","year":"1953","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2013.04.016_bib0135","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-4632.2004.02501.x","article-title":"Pemphigus: analysis of 1209 cases","volume":"44","author":"Chams-Davatchi","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0140","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2133.2009.09207.x","article-title":"Tunisian endemic pemphigus foliaceus is associated with the HLA-DR3 gene: anti-desmoglein 1 antibody-positive healthy subjects bear protective alleles","volume":"161","author":"Abida","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0145","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archdermatol.2012.1830","article-title":"Prognostic factors of paraneoplastic pemphigus","volume":"148","author":"Leger","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0150","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/archderm.1979.04010040006002","article-title":"Correlation of antibodies in skin and serum with disease severity in pemphigus","volume":"115","author":"Judd","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0190-9622(99)70183-0","article-title":"The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile","volume":"40","author":"Amagai","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0160","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0165","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archderm.1984.01650430127024","article-title":"Adjuvant therapy of pemphigus","volume":"120","author":"Bystryn","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0170","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/archderm.1976.01630310024005","article-title":"Pemphigus \u2013 20-year review of 107 patients treated with corticosteroids","volume":"112","author":"Rosenberg","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0175","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/archderm.136.7.868","article-title":"Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus","volume":"136","author":"Ioannides","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0180","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus","volume":"142","author":"Beissert","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0185","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0190","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A randomized double-blind trial of intravenous immunoglobulin for pemphigus","volume":"60","author":"Amagai","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.144.1.25","article-title":"Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris","volume":"144","author":"Werth","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0200","doi-asserted-by":"crossref","first-page":"175ra30","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.revmed.2013.04.016_bib0205","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2013.04.016_bib0210","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid \u2013 Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0215","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaad.2008.02.035","article-title":"IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not buflous, pemphigoid","volume":"58","author":"Lazarova","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0220","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/1523-1747.ep12876206","article-title":"Studies of cicatricial pemphigoid antibodies \u2013 Immunoelectron microscopy and immunoblot analysis","volume":"94","author":"Bernard","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0225","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1079-2104(99)70110-1","article-title":"A retrospective study of the management of oral mucous membrane pemphigoid with dapsone","volume":"88","author":"Ciarrocca","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.revmed.2013.04.016_bib0230","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2133.2000.03600.x","article-title":"An open clinical trial of sulphamethoxypyridazine in the treatment of mucous membrane pemphigoid","volume":"143","author":"Thornhill","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0235","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2133.1995.tb00727.x","article-title":"Minimizing cicatricial pemphigoid orodynia with minocycline","volume":"132","author":"Poskitt","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0240","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/bjd.12041","article-title":"Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid","volume":"168","author":"Munyangango","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0245","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1365-4632.2010.04707.x","article-title":"Therapeutic effect of etanercept in anti-laminin 5 (laminin 332) mucous membrane pemphigoid","volume":"50","author":"Schulz","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0250","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1067\/mjd.2001.114746","article-title":"Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent","volume":"45","author":"Megahed","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0255","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/archdermatol.2011.167","article-title":"Rituximab for severe mucous membrane pemphigoid safe enough to be drug of first choice?","volume":"147","author":"Hertl","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0260","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in 3 French regions","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0265","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0190-9622(94)70015-X","article-title":"Drug-induced linear IgA bullous dermatosis \u2013 Report of 6 cases and review of the litterature","volume":"30","author":"Kuechle","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0270","first-page":"692","article-title":"Linear IGA dermatosis associated with ulcerative colitis","volume":"16","author":"Fernandez-Guarino","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0275","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1468-3083.2007.02553.x","article-title":"Clinical and immunopathological heterogeneity of 22 cases of linear IgA bullous dermatosis","volume":"22","author":"Sobjanek","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0280","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1523-1747.ep13070851","article-title":"Diagnosis of adult linear IgA dermatosis by immunoelectronmicroscopy in 16 patients with linear IgA deposits","volume":"92","author":"Prost","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0285","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0738-081X(91)90030-O","article-title":"Linear IgA bullous dermatosis of adults","volume":"9","author":"Chorzelski","year":"1991","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0290","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-4632.2009.03886.x","article-title":"Epidermolysis bullosa acquisita: concise review and practical considerations","volume":"48","author":"Lehman","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0295","first-page":"570","article-title":"Black patients of African descent and HLA-DRB1*1503 frequency overrepresented in epidermolysis bullosa acquisita","volume":"79","author":"Loiseau","year":"2012","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.revmed.2013.04.016_bib0300","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1111\/1523-1747.ep12275505","article-title":"Epidermolysis bullosa-acquisita of the immunopathological type (dermolytic pemphigoid)","volume":"85","author":"Briggaman","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0305","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12016-007-0027-6","article-title":"Autoimmunity to type VII collagen: Bullosa acquisita","volume":"33","author":"Woodley","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0310","doi-asserted-by":"crossref","first-page":"E224","DOI":"10.1111\/j.1468-3083.2012.04617.x","article-title":"Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions","volume":"27","author":"Kim","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.revmed.2013.04.016_bib0315","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archderm.138.3.380","article-title":"Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita","volume":"138","author":"Kirtschig","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2013.04.016_bib0320","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/gut.25.2.151","article-title":"Dermatitis-herpetiformis \u2013 Diagnosis, diet and demography","volume":"25","author":"Gawkrodger","year":"1984","journal-title":"Gut"},{"key":"10.1016\/j.revmed.2013.04.016_bib0325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.308.6920.13","article-title":"Risk of lymphoma in patients with dermatitis-herpetiformis","volume":"308","author":"Sigurgeirsson","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2013.04.016_bib0330","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1523-1747.2003.12609.x","article-title":"The autoantigen of anti-p200 pemphigoid is an acidic noncollagenous N-linked glycoprotein of the cutaneous basement membrane","volume":"121","author":"Shimanovich","year":"2003","journal-title":"J Invest Dermatol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313005134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313005134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:33:07Z","timestamp":1759336387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866313005134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0248866313005134"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2013.04.016","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les maladies bulleuses auto-immunes","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2013.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}